Literature DB >> 16000366

Increased blood vessel density provides the mole rat physiological tolerance to its hypoxic subterranean habitat.

Aaron Avivi1, Imad Shams, Alma Joel, Orit Lache, Andrew P Levy, Eviatar Nevo.   

Abstract

The blind subterranean mole rat superspecies Spalax ehrenbergi has evolved adaptations that allow it to survive and carry out intensive activities in its highly hypoxic underground sealed burrows. A key component of this adaptation is a higher capillary density in some Spalax tissues, primarily in muscles used in digging and in other energetic activities, resulting in a shorter diffusion distance for oxygen. Vascular endothelial growth factor (VEGF) is an angiogenic factor that is critical for angiogenesis during development and is found in response to tissue ischemia. We demonstrate here that due to physiological differences, the Spalax muscle regulatory mechanism for VEGF is different than in Rattus muscle. In vivo, the constitutive level of the VEGF mRNA and the mRNA levels of its transcriptional regulator HIF-1alpha and its mRNA stabilizer HuR are significantly higher in Spalax muscle than in Rattus muscle. Furthermore, as opposed to Rattus, the mRNA levels of HIF-1alpha, HuR, VEGF, as well as that of LDH-A, the enzyme that catalyzes the production of lactate, an accepted marker of anaerobic metabolism, are not increased in Spalax after hypoxia. However, ex vivo, when oxygenation by blood vessels is no longer relevant, the expression pattern of all these genes is similar in the two rodents under both normoxic and hypoxic conditions. Our studies provide evidence that the highly vascularized muscle in Spalax, the most energy consuming tissue during digging, is resistant to the effects of oxygen deprivation. The significance of these results with respect to ischemic vascular disease is abundantly clear.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000366     DOI: 10.1096/fj.04-3414fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  29 in total

1.  Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant.

Authors:  Nicola J Nasser; Eviatar Nevo; Itay Shafat; Neta Ilan; Israel Vlodavsky; Aaron Avivi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-04       Impact factor: 11.205

2.  Neuroglobin, cytoglobin, and myoglobin contribute to hypoxia adaptation of the subterranean mole rat Spalax.

Authors:  Aaron Avivi; Frank Gerlach; Alma Joel; Stefan Reuss; Thorsten Burmester; Eviatar Nevo; Thomas Hankeln
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

3.  The muscle ankyrin repeat proteins are hypoxia-sensitive: in vivo mRNA expression in the hypoxia-tolerant blind subterranean mole rat, Spalax ehrenbergi.

Authors:  Mark Band; Alma Joel; Aaron Avivi
Journal:  J Mol Evol       Date:  2009-12-05       Impact factor: 2.395

4.  An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation.

Authors:  Orly Ravid; Imad Shams; Nathalie Ben Califa; Eviatar Nevo; Aaron Avivi; Drorit Neumann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

Review 5.  Adaptive and maladaptive expression of the mRNA regulatory protein HuR.

Authors:  Suman Govindaraju; Beth S Lee
Journal:  World J Biol Chem       Date:  2013-11-26

6.  Antioxidant activity in Spalax ehrenbergi: a possible adaptation to underground stress.

Authors:  Beatriz Caballero; Cristina Tomás-Zapico; Ignacio Vega-Naredo; Verónica Sierra; Delio Tolivia; Rüdiger Hardeland; María Josefa Rodríguez-Colunga; Alma Joel; Eviatar Nevo; Aaron Avivi; Ana Coto-Montes
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2006-02-15       Impact factor: 1.836

7.  Molecular structure of heparan sulfate from Spalax. Implications of heparanase and hypoxia.

Authors:  Elina Sandwall; Sabrina Bodevin; Nicola J Nasser; Eviatar Nevo; Aaron Avivi; Israel Vlodavsky; Jin-Ping Li
Journal:  J Biol Chem       Date:  2008-12-09       Impact factor: 5.157

8.  Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis.

Authors:  Nicola J Nasser; Aaron Avivi; Itay Shafat; Evgeny Edovitsky; Eyal Zcharia; Neta Ilan; Israel Vlodavsky; Eviatar Nevo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

Review 9.  HuR function in disease.

Authors:  Subramanya Srikantan; Myriam Gorospe
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

Review 10.  Nontraditional systems in aging research: an update.

Authors:  Justyna Mikuła-Pietrasik; Martyna Pakuła; Małgorzata Markowska; Paweł Uruski; Ludwina Szczepaniak-Chicheł; Andrzej Tykarski; Krzysztof Książek
Journal:  Cell Mol Life Sci       Date:  2020-10-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.